BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 909219)

  • 1. [Sensitivities of atypical mycobacteria to various drugs. III. Sensitivities of M. intracellulare to antituberculous drugs in triple combinations (author's transl)].
    Kuze F; Takeda S; Maekawa N
    Kekkaku; 1977 Jul; 52(7):331-8. PubMed ID: 909219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivities of atypical mycobacteria to various drugs. IV. Sensitivities of atypical mycobacteria originally isolated in the U.S.A. to antituberculous drugs in triple combinations (author's transl)].
    Kuze F; Naito Y; Takeda S; Maekawa N
    Kekkaku; 1977 Oct; 52(10):505-13. PubMed ID: 599768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivities of atypical mycobacteria to various drugs. V. Sensitivities of Mycobacterium intracellulare to some aminoglycoside and peptide antibiotics (author's transl)].
    Naito Y; Kuze F; Maekawa N
    Kekkaku; 1979 Aug; 54(8):423-7. PubMed ID: 537304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivities of atypical mycobacteria to various drugs. VI. Antibacterial effects of sulfonamides and their combinations in vitro].
    Sakurai N; Kuze F
    Kekkaku; 1983 Aug; 58(8):415-20. PubMed ID: 6663959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
    Toyohara M
    Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivities of atypical mycobacteria to various drugs. I. Sensitivities to antituberculous drugs (author's transl)].
    Kuze F; Takeda S; Maekawa N
    Kekkaku; 1974 Jun; 49(6):151-6. PubMed ID: 4410839
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined versus single-drug studies on susceptibilities of Mycobacterium avium-intracellulare to antituberculosis drugs on Ogawa medium].
    Kuze F; Sakurai N; Ogino F; Togawa S
    Kekkaku; 1986 Jun; 61(6):341-9. PubMed ID: 3747326
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs.
    Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N
    Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transamination processes in mycobacteria with different biological properties].
    Fadeeva NI; Golyshevskaia VI; Bibergal' EA; Safonova SG
    Probl Tuberk; 1990; (9):62-4. PubMed ID: 2274513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriostatic effects of sulfadimethoxine and kitasamycin on Mycobacterium avium-M. intracellulare complex].
    Tsukamura M
    Kekkaku; 1983 Apr; 58(4):247-50. PubMed ID: 6632486
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance to antitubercular drugs of atypical Mycobacterium pathogenic to man].
    Casal Román M
    Rev Clin Esp; 1978 Feb; 148(4):343-5. PubMed ID: 653055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].
    Ungheri D; Morvillo E; Sanfilippo A
    G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
    Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M
    Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity of enviomycin for atypical mycobacteria. 1. Antibacterial activity in vitro (author's transl)].
    Toyohara M
    Kekkaku; 1978 Apr; 53(4):255-60. PubMed ID: 661057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on decrease of drug activity during storage of drug-containing media for drug resistance test of tubercle bacilli (author's transl)].
    Ohsato T; Takaya H
    Kekkaku; 1978 Feb; 53(2):91-7. PubMed ID: 633706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.